22q11 Deletion Syndrome
📧 Sign up to get email alerts when something new happens for 22q11 Deletion Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome [Phase 4]
An ongoing Phase 4 clinical study led by The Chaim Sheba Medical Center is examining psychiatric and cognitive phenotypes in 22q11.2 deletio…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE) [Phase 2]
Open-label Phase 2 trial evaluating ZYN002 transdermal gel in children and adolescents with 22q11.2 Deletion Syndrome has completed enrollme…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome [NA]
A clinical trial is recruiting to evaluate whether transcranial alternating current stimulation (tACS) can improve executive function in ind…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Understanding of Psychotic Disorders in Children With 22q11.2DS [NA]
A clinical trial is recruiting to understand psychotic disorders in children with 22q11.2 deletion syndrome.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
A clinical trial is recruiting to examine how genetic factors influence the severity of DiGeorge syndrome/22q11.2 Deletion Syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders [Phase 2]
A Phase 2 trial is evaluating sertraline versus placebo for anxiety in children and adolescents with neurodevelopmental disorders, including…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Mindfulness Program for Adolescents With 22q11DS [NA]
The clinical trial evaluating a mindfulness program for adolescents with 22q11.2 deletion syndrome has completed and results have been poste…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Arithmetic Abilities in Children With 22q11.2DS [NA]
A clinical trial evaluating arithmetic abilities in children with 22q11.2 Deletion Syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: NB-001 in Children and Adolescents With 22q11 Deletion Syndrome [Phase 2]
NB-001 has completed a Phase 2 trial in children and adolescents with 22q11.2 deletion syndrome, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome [NA]
This clinical trial update reports that a study evaluating neuroprotective effects of risperidone in individuals with 22q11.2 Deletion Syndr…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
The sponsor reports completion of a clinical trial studying Velocardiofacial/DiGeorge syndrome (22q11.2 deletion syndrome).
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome [NA]
The study evaluated computerized cognitive skills training in adolescents with Velocardiofacial syndrome and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
A completed clinical trial investigating the resolution of the primary immune defect in individuals with 22q11.2 deletion syndrome.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Cognitive Remediation in 22q11DS [NA]
A completed clinical trial evaluating cognitive remediation in individuals with 22q11.2 Deletion Syndrome (Velo-Cardio-Facial Syndrome).
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome. [Phase 2, Phase 3]
Clinical trial update for indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11.2 deletion syndrom…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Non-invasive Prenatal Diagnostic Validation Study
The study completed validation of a non-invasive prenatal diagnostic test for fetal chromosomal abnormalities.
-
CLINICAL_TRIALS trial_result · 2008-11-03Clinical Trial Update: Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome
A completed clinical trial evaluated middle and inner ear malformations in children with Velocardiofacial syndrome (22q11.2 deletion syndrom…
-
CLINICAL_TRIALS research · 2007-05-04Clinical Trial Update: Prevalence and Clinical Spectrum of the 22q11 Deletion
This clinical trial update summarizes the prevalence and clinical spectrum of 22q11.2 deletion syndrome.
-
CLINICAL_TRIALS research · 2006-10-13Clinical Trial Update: Genetics and Psychopathology in the 22q11 Deletion Syndrome
This clinical trial from UMC Utrecht investigates genetics and psychopathology in individuals with 22q11.2 Deletion Syndrome; the study stat…